Table 1 Eligibility criteria

 1

Anxiety disorder, mood disorder, or adjustment disorder is the main diagnosis (most interfering and severe)^a

 2

The patient is over 18 years of age

 3

The patient is fluent in the language in which therapy is performed (Spanish in the present study)

 4

The patient is able to attend to the evaluation and treatment sessions and signs the informed consent form

 5

Patients taking pharmacological treatment for their emotional disorder are asked to maintain the same dosages and medications for at least 3 months prior to enrolling in the study and during the whole treatment^b

 1

The patient presents a severe condition that would require to be prioritized for treatment, so that an interaction between both interventions cannot be ruled out. These include a severe mental disorder (bipolar disorder, schizophrenia, or an organic mental disorder),suicide risk at the time of assessment, or substance use in the last three months (excluding cannabis, coffee, and / or nicotine)

 2

The patient has previously received 8 or more sessions of psychological treatment with clear and identifiable CBT principles within the past 5 years.